Psychedelic compounds directly excite 5-HT<sub>2A</sub> layer V medial prefrontal cortex neurons through 5-HT<sub>2A</sub> Gq activation.
Abstract
Psilocybin, and its active metabolite psilocin, have seen renewed interest due to studies suggesting potential therapeutic utility. 5-Hydroxytryptamine2A receptors (5-HT<sub>2A</sub>Rs) are primary mediators of the psychoactive effects of psychedelics in animals and humans, but the underlying neurobiological mechanisms remain poorly understood. Functional magnetic resonance imaging identified significant psilocin-induced increases in medial prefrontal cortex (mPFC) activity, a site of enriched 5-HT<sub>2A</sub>R expression. We identified a population of 5-HT<sub>2A</sub>R neurons in the prelimbic/anterior cingulate mPFC. Psilocin and the 5-HT<sub>2A</sub>R-selective compound 25-CN-NBOH increased excitability, and stimulated firing across a range of current injections in these neurons that was both 5-HT<sub>2A</sub>R and Gα<sub>q</sub> dependent. Similar effects were observed with a novel, non-hallucinogenic psychedelic compound. These findings provide valuable insight into the specific role of 5-HT<sub>2A</sub>R-containing neurons in psychedelic-associated plasticity in mPFC regions that are likely implicated in the clinical effects of psychedelics and further identify membrane-bound 5-HT<sub>2A</sub>Rs and subsequent intracellular Gα<sub>q</sub> signaling as therapeutic targets.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.